Gates Foundation Backs Merck’s Antiviral Covid Pill With $120 Million Pledge To Boost Access Across Poorer Nations The foundation said the money will support the manufacturer of the potentially game-changing drug if it is approved by regulators, citing promising results from a late-stage clinical trial.